— Know what they know.
Not Investment Advice

ACTU NASDAQ

Actuate Therapeutics Inc
1W: +20.4% 1M: -37.0% 3M: -41.5% YTD: -86.4% 1Y: -88.2%
$0.82
-0.07 (-7.89%)
 
Weekly Expected Move ±19.2%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $19.6M mcap · 9M float · 3.73% daily turnover · Short 61% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-20M
Net Income
+17.1% YoY
$-20M
Free Cash Flow
+13.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE2457.6%
ROA-336.2%
ROIC541.3%

Valuation

P/E-0.9
P/B19.8
EV/EBITDA-1.6

Leverage

Debt/Equity0.41
Current Ratio1.25
Interest Cov.-1011.2x

Quality Scores

Piotroski F3/9
Altman Z-52.03
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms